FULGENT GENETICS, INC. Accrued Liabilities, Current
FULGENT GENETICS, INC. (FLGT) had Accrued Liabilities, Current of $23.51 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-07-30
- 2026-06-30: Accrued Liabilities, Current $23.51M.
- 2026-03-31: Accrued Liabilities, Current $34.90M.
- 2025-12-31: Accrued Liabilities, Current $34.06M.
- 2025-09-30: Accrued Liabilities, Current $23.01M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $23.51M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $34.90M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $34.06M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $23.01M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $21.70M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $16.69M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $24.28M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $23.86M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $26.43M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $25.92M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $30.74M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $21.03M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $22.23M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $21.09M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $24.98M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $25.10M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $27.10M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $11.85M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $17.69M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $8.45M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $5.47M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.75M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.02M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.33M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $1.63M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.33M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $1.35M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.26M 10-K · filed 2020-03-13 | $1.43M 10-K · filed 2019-03-22 |
| 2018-09-30 | $1.23M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.18M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $1.06M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $911.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $781.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $902.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $745.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $436.00K 10-K · filed 2018-03-20 | |
| 2016-09-30 | $471.00K 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $199.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |